date:Jun 16, 2012
middle ground.
Maybe a probational permission of the health claim is an appropriate reflection of the fact that for the second time, EFSA has not given the claim an outright rejection.Given the large body of evidence that already exists, as well as the large number of studies still underway, DSM and Kemin remain perfectly confident that EFSA will ultimately recognise the beneficial effects of lutein in the field of eye-health.
NDA verdict
The lutein sector was pinning its hopes on the main ad